With extensive experience in the life sciences and technology sectors, the fund manager has been instrumental in driving innovation across Europe and North America. The portfolio comprises over 30 investments, primarily in early to growth-stage companies, emphasizing an operator-first strategy that leverages deep industry insights. Notable exits include successful IPOs and acquisitions, showcasing a commitment to maximizing value creation. Their strategic approach combines data-driven decision-making with a thematic focus on advancing healthcare solutions and cutting-edge technologies.